GBT-18713

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGBT-18713
Drug Alias Nameoral therapeutic (Global Blood Therapeutics)GBT-18713
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlobal Blood Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlobal Blood Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A